What happened
Drgem / Supply Contract Signed / (2026.07.22) Supply Contract Signed
Single Sale/Supply Contract Signed
1. Content of the sale/supply contract: supply contract for medical devices (X-ray) 2. Contract details: Whether conditional: not applicable; Confirmed contract value: KRW 19,259,280,612; Conditional contract value: -; Total contract value: KRW 19,259,280,612; Most recent revenue: KRW 102,746,224,632; Ratio to revenue: 18.74% 3. Counterparty: -; Most recent revenue: -; Main business: -; Relationship with the Company: -; Performance of similar contracts with the Company over the past 3 years: not applicable 4. Sales/supply region: Turkey 5. Contract term: Start date: 2026-07-21; End date: 2026-12-20 6. Key contract terms: Down payment/advance payment: No Payment terms, etc.: payment within 160 days of product shipment 7. Sales/supply method: In-house production: applicable; Outsourced production: not applicable; Other: - 8. Contract (order) date: 2026-07-21 9. Matters relating to confidentiality deferral: Deferral deadline: 2026-12-20; Reason for deferral: at the counterparty's request to keep its trade secrets confidential 10. Other matters relevant to investment decisions: - The most recent revenue in the above contract details is based on the consolidated financial statements as of the end of 2025. - The above contract value is USD 12,995,466, converted using the Seoul Money Brokerage Services base exchange rate of KRW 1,482 as of July 21, 2026. - The counterparty's information (the counterparty's name, most recent revenue, relationship with the Company) is omitted above at the counterparty's request to protect its trade secrets. - The contract term start date and the contract (order) date are based on the date the signed proforma invoice was received. - The contract term end date is the product delivery deadline and may change through consultation between the parties. Related disclosure: -
| Filed | 2026-07-22, Supply contract signed |
|---|---|
| Source | DART rcept 20260722900385 → open original filing |
Source: DART. Information only, not investment advice.
